突变特征的动态影响食道腺癌的演变
Sujath Abbas1, Oriol Pich2, Ginny Devonshire3
1Early Cancer Institute, University of Cambridge, Cambridge, UK.
Nature communications
|July 15, 2023
概括
揭示了食道腺癌的突变过程,从早期的巴雷特食道到高级阶段. 特定的特征 (SBS17a/b) 和DNA修复途径的改变,特别是基切除修复缺陷,影响癌症的进展和预后.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 癌症生物学 癌症生物学
背景情况:
- 癌症的发展是由各种突变过程驱动的.
- 这些过程的动态在食道腺癌的全谱,从癌前病变到晚期疾病,仍然不清楚.
研究的目的:
- 调查影响食道腺癌瘤发生的突变性过程.
- 在不同的疾病阶段分析这些过程,包括巴雷特食道,原发性瘤和转移性疾病.
主要方法:
- 对997例食道腺癌的突变格局的分析.
- 鉴定和表征突变特征和DNA损伤修复途径的变化.
主要成果:
- 突变格局由C[T>C/G]T替代特征 (SBS17a/b) 主导,与TP53突变,增殖和进展有关.
- 在初级瘤中,APOBEC突变是微妙但一致的信号.
- 在DNA损伤修复途径 (同类重组,基切除修复,核酸切除修复,转化合成) 的变化是频繁的 (高达50%) 和脱离转录.
- 基切除修复缺陷与预后不佳相关.
结论:
- 这项研究阐明了食道腺癌的突变病因,跨越其发育阶段.
- 关键的突变特征和DNA修复途径的改变被确定为疾病进展的驱动因素.
- 切除的修复缺陷代表了食道腺癌的显著负面预后因素.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
12.1K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.1K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Mismatch Repair
4.9K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.9K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Spontaneous and Induced Mutations
42
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
42


